Filter
373
Text search:
resurgence
Featured
Recommendations
38
New Publications
94
Language
Document type
No document type
165
Studies & Reports
101
Strategic & Response Plan
35
Guidelines
34
Manuals
11
Situation Updates
11
Fact sheets
10
Training Material
3
Infographics
2
Resource Platforms
1
Countries / Regions
Global
24
Congo, Democratic Republic of
15
Western and Central Europe
14
Guinea
11
Sierra Leone
11
India
11
Africa
10
Liberia
8
Ethiopia
8
Uganda
8
Haiti
8
South Africa
8
Nigeria
7
Syria
7
Afghanistan
6
Zambia
6
Malawi
6
Central African Republic
6
Brazil
6
Yemen
6
Latin America and the Carribbean
6
Venezuela
6
Somalia
5
South Sudan
5
Eastern Europe
5
Bangladesh
4
Myanmar / Burma
4
West and Central Africa
4
Middle East and North Africa
4
Burkina Faso
3
Senegal
3
Mali
3
Zimbabwe
3
Pakistan
3
Jordan
3
Germany
3
Lebanon
3
Turkey
3
Tanzania
3
Mozambique
3
Lesotho
3
East and Southern Africa
3
South–East Asia Region
3
Asia
3
Togo
2
Nepal
2
Kenya
2
Rwanda
2
Sudan
2
Benin
2
Eastern Europe and Central Asia
2
Palestine
2
Vietnam
2
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Philippines
1
Iraq
1
Chad
1
Cambodia
1
China
1
Burundi
1
Ukraine
1
Colombia
1
Ecuador
1
Botswana
1
Greece
1
Libya
1
Angola
1
Madagascar
1
Mexico
1
Paraguay
1
Albania
1
Djibouti
1
Armenia
1
Iran
1
Georgia
1
France
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
32
Public Health
24
Key Resources
11
Women & Child Health
5
Capacity Building
3
Annual Report MEDBOX
1
Protection & Security
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
71
NTDs
26
Ebola
25
HIV
23
TB
20
Rapid Response
18
Planetary Health
12
Cholera
11
Mental Health
11
Natural Hazards
10
Conflict
9
Refugee
9
Health Financing Toolbox
7
Polio
5
Global Health Education
5
AMR
5
Caregiver
5
Disability
3
Pharmacy
3
NCDs
2
Zika
1
Specific Hazards
1
Social Ethics
1
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re
...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b
...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci
...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
Guidance on the prioritization of insecticide-treated nets in situations where resources are limited
In the context of limited resources, national malaria programmes may need to decide on how to prioritize all WHO-recommended interventions . This guidance document has been developed to support national malaria programmes in prioritization decisions, specifically on the deployment scope and product
...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co
...
La filariose lymphatique (FL) est une maladie évitable, incapacitante et défigurante, due à une infestation par des filaires parasites des espèces Wuchereria bancrofti, Brugia malayi et B. timori. On estime que 51,4 millions de personnes sont infectées dans le monde. Le lymphœdème et l’hydr
...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
event-based surveillance (EBS) using a multisectoral, One Health approach. To
...
WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended
2nd edition. This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygiene services to underserved population affected by many neglected tropical diseases. The
...
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.
Since the last situation report on the multi-country outbreak of cholera was published on 1 June 2023 (covering data reported until 15 of May), no new country reported a cholera outbreak. In total, 24 countries have reported cases since the beginning of 2023. The WHO African Region remains the most
...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan
...
The 2022 Financing for Sustainable Development Report identifies a “great finance divide” as a main driver of the divergent recovery. Developed countries were able to borrow record sums at ultra-low interest rates to support their people and economies, but the pandemic response and investment in
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
This report seeks to uncover the extent to which global goals crowd in international financing, inform domestic policy priorities, and navigate progress toward development outcomes in low- and middle-income countries (LICs and MICs). Our report:
Provides a historical perspective on how ODA financin
...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the
...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est
...
This action plan is intended for senior-level decision-makers in ministries of health, malaria
programme managers, entomologists, and epidemiologists working on malaria and other vectorborne diseases programmes. It is also intended for decision-makers and technical and advocacy
staff at other orga
...
